The Blood Cancer Decoy: Why Some Lymphoma Patients Stop Responding to Treatment
For patients diagnosed with aggressive blood cancers, receiving a proven targeted therapy offers a clear path toward a cure.
Search results for "Abl Bio"
117 Workplace Accidents Recognized at 25 Major Korean Pharma and Biotech Firms Over Five Years
A review of 25 major South Korean pharmaceutical and biotechnology companies revealed 117 recognized industrial accidents over the past five years.
Unlocking the Mystery of Bladder Pain: Researchers Map Cellular Network Driving Interstitial Cystitis
Sharp, stinging pelvic pain and dozens of exhausting trips to the bathroom in a single day—these are the debilitating...
Japanese Medical Scholars Visit Daegu, Praising South Korea's Advanced Healthcare and Rich Cultural Heritage
South Korea’s advanced medical infrastructure and deep cultural heritage left a lasting impression on prominent figures...
Resetting the Body Clock: Smartphone App Cuts Mood Disorder Relapse Rates to One-Third
"I’m taking my medication faithfully—so why is this happening again?" It is a deeply frustrating question that patients...
Umbilical Cord-Derived Stem Cell Therapy Offers New Hope for Treatment-Resistant Hair Loss
For many individuals experiencing hair loss, investing significant time and money into treatments does not always...
Unmasking Glioblastoma’s Accomplice: Researchers Identify Hidden Protein Network Driving Brain Tumor Recurrence
"I had surgery and I even went through radiation—so why did it come back?" Families of glioblastoma patients face this...
How AI and 3D Technology Are Setting a New Standard for Dental Implants
Mr. A, a man in his early 60s, has been putting off an implant consultation for three months after losing two molars in...
Seizure- and Recurrence-Prone Glioma: First New Drug in 20 Years
Being diagnosed with a brain tumor in your 30s or 40s—when you are building your career, raising children, and staying...
Samsung Bioepis Expands Global Open Innovation via Partnership With Chinese Biotech Hub
Samsung Bioepis announced on the 29th that it has signed a memorandum of understanding with Atlalt Innovation Center, a...